Granules India and Greenko ZeroC Plan Green Pharma Zones
Granules India, a Hyderabad-based pharma company, is partnering compatriot clean energy company Greenko ZeroC to develop green zones for the sustainable manufacture of drugs and their intermediates.
The first zone will be developed in Kakinada, Andra Pradesh, where Granules will build a greenfield facility based on sustainability principles for the large-scale manufacturing of key starting materials, intermediates, APIs and fermentation-based products.
The cost of the project, which will be implemented in phases, is estimated at $242 million over five years.
Greenko ZeroC will supply carbon-free energy, also enabling the production of green hydrogen and its various chemical derivatives, which Granules will use to make products such as dicyandiamide (DCDA), paracetamol and metformin, among others.
Anil Kumar Chalamalasetty, Greenko’s CEO and managing director, said the “innovative and pioneering partnership will propel the transformation of industrial manufacturing to be more sustainable and competitive.”
Granules India has seven manufacturing facilities in total – six are based in India (Hyderabad and Visakhapatnam) and one is in the US (Chantilly, Virginia).
Author: Elaine Burridge, Freelance Journalist
